Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells

BACKGROUND: Cholangiocarcinoma (CCA) is a fatal cancer with high resistance to anticancer drugs. The development of new drugs or compounds to be used alone or in combination with currently available chemotherapeutic agents to improve the treatment of CCA is needed. Compound A (CpdA), which is a smal...

Descripción completa

Detalles Bibliográficos
Autores principales: Junking, Mutita, Rattanaburee, Thidarath, Panya, Aussara, Budunova, Irina, Haegeman, Guy, Yenchitsomanus, Pa-Thai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779449/
https://www.ncbi.nlm.nih.gov/pubmed/32986368
http://dx.doi.org/10.31557/APJCP.2020.21.9.2673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779449/
https://www.ncbi.nlm.nih.gov/pubmed/32986368
http://dx.doi.org/10.31557/APJCP.2020.21.9.2673

Ejemplares similares